C.E. Rasmussen

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas

Jocelyn de Heer, C.E. Rasmussen, D.H. Coy et al. · Diabetologia · 2008 · 237 citations · Full text

Receptor Subtype 2, Signal Transduction, Biochemistry +10

Heart Rate, Heart Rate Variability, and Arrhythmias in Dogs with Myxomatous Mitral Valve Disease

C.E. Rasmussen, T. Falk, N.E. Zois et al. · Journal of Veterinary Internal Medicine · 2011 · 79 citations · Full text

Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis

Akinori Uruha, Yves Allenbach, J.L. Charuel et al. · Neuropathology and Applied Neurobiology · 2018 · 74 citations · Full text

Lower-body fat mass as an independent marker of insulin sensitivity—the role of adiponectin

B Buemann, Oluf Pedersen, Eva Black et al. · International Journal of Obesity · 2005 · 62 citations

Obesity, Metabolic Syndrome, Body Composition +12

TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3–Related Skeletal Dysplasias

Vibeke Breinholt, C.E. Rasmussen, Per Mygind et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 60 citations · Full text